KIT and gastrointestinal stromal tumor: Among the 74 small GIST samples in this study, sequencing results revealed that the C-KIT mutation was predominant (76%, 56/74), and exon 11 of KIT was found to be a hotspot that accounted for 65% of the mutations (48/74).